HGA
GSK icon

Hobbs Group Advisors’s GSK GSK Stock Holding History

Hobbs Group Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-160
Closed -$6.54K – 342
2024
Q3 		$6.54K Hold
160
– – ﹤0.01% 469
2024
Q2 		$6.16K Buy
+160
New +$6.73K ﹤0.01% 435
2023
Q4 		$5.93K Buy
+160
New +$5.74K ﹤0.01% 403

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hobbs Group Advisors's GSK Position: Q4 2024 in Review

Hobbs Group Advisors sold out of GSK (GSK) in Q4 2024, closing a stake of 160 shares — an estimated $6.54K sold.

Hobbs Group Advisors first reported a position in GSK in Q4 2023 and held it in 3 quarters. The position peaked at $6.54K in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Hobbs Group Advisors reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Hobbs Group Advisors sold 160 GSK shares in Q4 2024, an estimated $6.54K.
  • Hobbs Group Advisors first reported a position in GSK in Q4 2023 and held it in 3 quarters.
  • Hobbs Group Advisors's GSK position peaked at $6.54K in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.